Is Milestone Pharmaceuticals Inc (MIST) overvalued? · $160.6M cap
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
This page asks whether Milestone Pharmaceuticals Inc (MIST) looks expensive on cached numbers — not a short thesis.
No cached income statement for MIST, so there is no earnings base to call rich or cheap.
MIST currently screens at market cap $160.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MIST 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MIST stock page for the full model, not this heading.
Not investment advice.